The world health Organisation said more information is requiring from Bharat Biotech which is seeking emergency use listing for its Covaxin vaccine for COVID-19. Then the latest status of COVID 19 vaccine with in WHO evaluation process guidance document dated May 18 on the WHO website said Bharat Biotech submitted expression of Interest on April 19. According the oath WHO submissions to for prequalification or listing under the emergency use procedure are confidential. Then if a product submitted for assessments is found to meet the criteria for listing, WHO will be publish the results.
Meanwhile Bharat Biotech International Limited has conveyed to the government that it has already submitted 90 percent of documents to WHO for obtaining emergency use listing for the Covaxin vaccine sources said on Monday. Nothing that Covaxin has already received regulatory approval from 11 countries, sources said there was also interest from other 11 companies in seven nations for technology transfer and production of Covaxin. The sources said the meeting with BBIL on the EUL was attended by the company’s managing director VK Krishna Mohan and his colleagues besides senior officers of the Ministry of Health, Department of Biotechnology and Ministry of External Affairs.